THE INFLUENCE OF BETA-RECEPTOR BLOCKING-DRUGS ON PLASMA-CATECHOLAMINE LEVELS IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：0
作者：
RAHN, KH
机构：
来源：
ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 1980年
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：54 / 57
页数：4
相关论文
共 12 条
[1]   POSSIBLE ROLE OF A BETA-ADRENOCEPTOR IN REGULATION OF NORADRENALINE RELEASE BY NERVE-STIMULATION THROUGH A POSITIVE FEEDBACK MECHANISM [J].
ADLERGRASCHINSK.E ;
LANGER, SZ .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 53 (01) :43-50
[2]   RELATIONSHIP OF PLASMA-LEVELS OF PINDOLOL IN HYPERTENSIVE PATIENTS TO EFFECTS ON BLOOD-PRESSURE, PLASMA-RENIN AND PLASMA NORADRENALINE LEVELS [J].
ANAVEKAR, SN ;
LOUIS, WJ ;
MORGAN, TO ;
DOYLE, AE ;
JOHNSTON, CI .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1975, 2 (03) :203-212
[3]   DECREASE IN PLASMA NORADRENALINE LEVELS FOLLOWING LONG-TERM TREATMENT WITH PRINDOLOL IN PATIENTS WITH ESSENTIAL HYPERTENSION [J].
BRECHT, HM ;
BANTHIEN, F ;
SCHOEPPE, W .
KLINISCHE WOCHENSCHRIFT, 1976, 54 (22) :1095-1105
[4]  
CAMPESE VM, 1977, CLIN RES, V25, pA88
[5]   SYMPATHETIC RESPONSIVENESS AND ANTIHYPERTENSIVE EFFECT OF BETA-RECEPTOR BLOCKADE IN ESSENTIAL HYPERTENSION [J].
DISTLER, A ;
KEIM, HJ ;
CORDES, U ;
PHILIPP, T ;
WOLFF, HP .
AMERICAN JOURNAL OF MEDICINE, 1978, 64 (03) :446-451
[6]   LONG-TERM TREATMENT OF MODERATE HYPERTENSION WITH BETA1-RECEPTOR BLOCKING-AGENT METOPROLOL .1. EFFECT ON MAXIMAL WORKING CAPACITY, PLASMA CATECHOLAMINES AND RENIN, URINARY ALDOSTERONE, BLOOD-PRESSURE AND PULSE-RATE UNDER BASAL CONDITIONS [J].
HANSSON, BG ;
DYMLING, JF ;
HEDELAND, H ;
HULTHEN, UL .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (04) :239-245
[7]  
LEEUW PW, 1977, ACTA MED SCAND, V202, P389
[8]   EFFECTS OF BETA-ADRENOCEPTOR BLOCKADE ON RENIN, ANGIOTENSIN, ALDOSTERONE AND CATECHOLAMINES AT REST AND DURING EXERCISE [J].
LIJNEN, PJ ;
AMERY, AK ;
FAGARD, RH ;
REYBROUCK, TM ;
MOERMAN, EJ ;
DESCHAEPDRYVER, AF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (02) :175-181
[9]  
LUTOLD BE, 1976, SCHWEIZ MED WSCHR, V106, P1735
[10]  
MORGANTI A, 1978, CLIN PHARMACOL THER, V23, P122
12